ÂÜÀòÂÒÂ×

Benjamin Douglass Hoehn, MD, PhD has a diverse work experience in the field of medicine and biotechnology. Benjamin Douglass is currently serving as the Clinical Development Leader at Annexon Biosciences since August 2021. Prior to this, they founded Neuroaxs LLC in 2017 and continues to be involved in the company. Benjamin Douglass also worked as a Program Physician for Zilucoplan-Neurodegeneration at UCB from August 2020 to August 2021. From 2019 to 2020, they held the position of Sr Director Medical Sciences, CNS at Kyowa Kirin Pharmaceutical Development.

Dr. Hoehn has also served as the Interim Chief Medical Officer at Next Science in 2018. Benjamin Douglass worked at Johnson & Johnson in various roles including Franchise Medical Leader for Codman Neurosurgery, Global Clinical Operation Leader for Codman Neurosurgery, and North Asia Medical Affairs and Safety Director from 2013 to 2017. Benjamin Douglass was involved in clinical development, strategic marketing, KOL development, and reviewed and developed educational program content during their time at Johnson & Johnson.

Prior to that, they worked as a Senior R&D Scientist at Genomictree Inc. in 2011 and as a Research Professor at Dongguk University from 2010 to 2011. Benjamin Douglass also gained business development and consulting experience at NEUROAXS LLC, NapticBio LLC, and Crystal Genomics Inc in 2008.

Dr. Hoehn's extensive work experience showcases their expertise in clinical development, medical affairs, strategic marketing, and business development in the field of medicine and biotechnology.

Dr. Benjamin Douglass Hoehn holds an impressive educational background in the field of neuroscience and medicine. Benjamin Douglass obtained their Bachelor of Arts (BA) degree in Neuroscience from Pomona College, where they studied from 1995 to 1997. Following this, they pursued further studies at Stanford University School of Medicine, where they earned their Medical Doctor (MD) degree in Medicine between 1998 and 2008. During their time at Stanford, Dr. Hoehn also undertook a Doctor of Philosophy (PhD) program in Neuroscience from 2001 to 2005. Moreover, they engaged in a Residency program in Neurosurgery at the University of Virginia. Additionally, Dr. Hoehn conducted a Post-Doctoral fellowship in Neuroscience at Stanford University School of Medicine.